HIGHLIGHTS
- who: Catherine Lambert MD PhD from the Division of Clinical Haematology, Centre have published the research: Nonreplacement therapy for hemophilia in low-income countries: experience from a prospective study in Ivory Coast, in the Journal: (JOURNAL)
SUMMARY
Emicizumab, hemophilia A, innovative therapies, Ivory Coast, low-income countries Essentials. [13] emicizumab raised the proportion of supply are not compatible with the ambition to provide efficacious, children on prophylaxis from 30% to 72% among boys aged and amp;lt;13 years in well-tolerated, and persistent prevention of bleeds among all children the Ivory Coast . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.